CLIC1 and glioblastoma: Although all these drugs have known limitation for chronic use in patients with GBM, these data demonstrated that CLIC1 inhibition is not only a pharmacological property of metformin, but it may represent a class effect endowed of all the compounds containing a biguanide structure.